Cholesterol Pathway Disruption Drives DCM Cell Damage
New research identifies abnormal cholesterol signalling as a driver of cardiomyocyte dysfunction in dilated cardiomyopathy, revealing links between lipid metabolism, ER structure, and sarcomere organisation.